Some health officials struggling with new monkeypox vaccine injection method

Some states and jurisdictions are hitting early bumps in their rollout of the US government’s new approach to expanding access and supplies to more at-risk Americans, local officials told ABC News. , because providers face a steep learning curve with new vaccinations. way.

Earlier this month, the Biden administration announced that it was launching a new plan to increase the nation’s supply of monkeypox vaccine by changing the method of injecting from traditional subcutaneous injections in the arm to the intradermal technique of small, shallow injections. Is.

The new intradermal technology requires only a fraction of the vaccine per shot. Instead of using one vial per vaccination, the approach produces a total of five vaccinations per vial, according to federal officials. At the time, these officers acknowledged that delivering a shot like this would require more technical skill.

Now, several state and local officials across the country have told ABC News that some of their physicians are struggling to get all five doses out of the vial.

“We’ve also heard reports from some of our providers that they are only able to extract three or four doses per vial,” Nikki Ostergaard, from the Washington State Department of Health, told ABC News.

Health officials in Texas confirmed to ABC News that although some providers have been able to successfully remove five doses from vials, others “cannot receive five doses.” In Maryland, a representative from the Department of Health also confirmed that she had heard anecdotal reports of issues.

The Association of Immunization Managers (AIM) confirmed to ABC News that its executive director, Claire Hannan, has also heard that some physicians are running into trouble with the extraction process, and thus, the organization is educating health officials on how to prepare them. working to do. Better injection process.

“The needles used make a difference. And AIM expects this to improve as physicians become more proficient in ID technology,” a representative for the organization said in a statement.

White House Deputy Coordinator for the National Monkeypox Response, Dr. Demetre Daskalakis told Stat News that his team had “definitely” heard about the issues arising from local jurisdictions, adding that the number of doses physicians are able to extract, with most reporting that they had to be taken up to three. Received five doses.

Concerns about intradermal approaches from local authorities

In the weeks after the US government announced changes to vaccination strategy, there were some initial concerns about local officials training health care providers on how to administer shots with the new technology.

New York State Health Commissioner Dr. Mary T. Bassett said during a press conference with Gov. Cathy Hochul this week that receiving an intradermal injection is “not as pleasant” as it can scarring and “more painful.”

“They are more complications on site, that they are not serious, but they are unpleasant,” Bassett said.

But officials said that given the current crisis, it is important to vaccinate as many people as possible.

“We struggle with not having enough doses. And our obligation in public health is to always do what’s best for most people and intradermal administration will expand our access to a scarce resource,” Bassett said at the press conference.

Hochul said this is “an interim approach until the challenges of the supply chain are broken,” and when an unlimited number of vaccines become available, the state may consider going back to the original way of administering the shots.

In New York City, Health Commissioner Dr. Ashwin Vasan said on Wednesday that it would take “a few weeks” for the city to fully transition to an intradermal approach as they educate local clinics on the practice, but transition is necessary because it ” actually it is. mandated by the federal government.”

“It is not optional,” Vasan told the city council meeting. “The federal government has made it clear that we won’t get any more vaccines until we switch, and that’s why we’re switching.”